GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grapefruit USA Inc (OTCPK:GPFT) » Definitions » Beneish M-Score

Grapefruit USA (Grapefruit USA) Beneish M-Score : -15.86 (As of May. 24, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Grapefruit USA Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -15.86 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Grapefruit USA's Beneish M-Score or its related term are showing as below:

GPFT' s Beneish M-Score Range Over the Past 10 Years
Min: -2132.18   Med: -7.05   Max: 30.63
Current: -15.86

During the past 13 years, the highest Beneish M-Score of Grapefruit USA was 30.63. The lowest was -2132.18. And the median was -7.05.


Grapefruit USA Beneish M-Score Historical Data

The historical data trend for Grapefruit USA's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grapefruit USA Beneish M-Score Chart

Grapefruit USA Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -2.04 30.63

Grapefruit USA Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Sep23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.63 4.35 -12.35 -15.01 -15.86

Competitive Comparison of Grapefruit USA's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Grapefruit USA's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grapefruit USA's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grapefruit USA's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Grapefruit USA's Beneish M-Score falls into.



Grapefruit USA Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Grapefruit USA for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0+0.528 * 0.0849+0.404 * 0.0494+0.892 * 0.0561+0.115 * 2.394
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 13.6802+4.679 * -1.811211-0.327 * 1.7835
=-15.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep23) TTM:Last Year (Dec21) TTM:
Total Receivables was $0.00 Mil.
Revenue was 0 + 0.003 + 0.024 + 0.006 = $0.03 Mil.
Gross Profit was -0.087 + -0.06 + -0.138 + -0.066 = $-0.35 Mil.
Total Current Assets was $0.04 Mil.
Total Assets was $1.55 Mil.
Property, Plant and Equipment(Net PPE) was $1.51 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.37 Mil.
Selling, General, & Admin. Expense(SGA) was $1.37 Mil.
Total Current Liabilities was $8.48 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Net Income was -0.37 + -0.758 + -1.365 + -0.484 = $-2.98 Mil.
Non Operating Income was 0.056 + 0.014 + -0.021 + 0.102 = $0.15 Mil.
Cash Flow from Operations was 0 + -0.036 + -0.024 + -0.257 = $-0.32 Mil.
Total Receivables was $0.28 Mil.
Revenue was 0.002 + 0.153 + 0.082 + 0.351 = $0.59 Mil.
Gross Profit was -0.19 + -0.193 + -0.075 + -0.073 = $-0.53 Mil.
Total Current Assets was $0.71 Mil.
Total Assets was $2.82 Mil.
Property, Plant and Equipment(Net PPE) was $1.85 Mil.
Depreciation, Depletion and Amortization(DDA) was $1.66 Mil.
Selling, General, & Admin. Expense(SGA) was $1.79 Mil.
Total Current Liabilities was $7.70 Mil.
Long-Term Debt & Capital Lease Obligation was $0.93 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0 / 0.033) / (0.278 / 0.588)
=0 / 0.472789
=0

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(-0.531 / 0.588) / (-0.351 / 0.033)
=-0.903061 / -10.636364
=0.0849

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (0.039 + 1.506) / 1.552) / (1 - (0.714 + 1.845) / 2.816)
=0.00451 / 0.091264
=0.0494

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=0.033 / 0.588
=0.0561

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1.664 / (1.664 + 1.845)) / (0.372 / (0.372 + 1.506))
=0.474209 / 0.198083
=2.394

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1.372 / 0.033) / (1.787 / 0.588)
=41.575758 / 3.039116
=13.6802

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 8.484) / 1.552) / ((0.927 + 7.704) / 2.816)
=5.466495 / 3.064986
=1.7835

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-2.977 - 0.151 - -0.317) / 1.552
=-1.811211

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Grapefruit USA has a M-score of -15.86 suggests that the company is unlikely to be a manipulator.


Grapefruit USA Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Grapefruit USA's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Grapefruit USA (Grapefruit USA) Business Description

Traded in Other Exchanges
N/A
Address
10866 Wilshire Boulevard, Suite 225, Los Angeles, CA, USA, 90024
Grapefruit USA Inc manufactures and distributes cannabis-based products. Its extraction lab produces high-quality distillate or Honey Oil from trim that Grapefruit sources through its Distribution arm. The company is a premier licensed Distributor of all things cannabis throughout the State of California. It serves licensed Medicinal and Recreational Dispensaries. Its patented product is Hourglass Cream. Grapefruit owns and operates a California-licensed cannabis extraction laboratory and wholesale distribution facility in the Coachillin' Canna-Business Park near Palm Springs, California.
Executives
Bradley J Yourist director, 10 percent owner, officer: Chairman and CEO 10866 WILSHIRE BLVD, #225, LOS ANGELES CA 90024
Daniel J. Yourist director, 10 percent owner, officer: Board of Directors and COO 10866 WILSHIRE BLVD, SUITE 225, LOS ANGELES CA 90024
Dane Medley director, officer: CEO/Chairman 10553 CAMARILLO STREET, TOLUCA LAKE CA 91602
Emilio Xavier Aguilera director, officer: Chief Financial Officer 16827 HALSEY STREET, GRANADA HILLS CA 91344
Dean Janes officer: CHIEF EXECUTIVE OFFICER 3200 W. VALHALLA DRIVE, BURBANK CA 91505
Christopher Sohn director, officer: President and COO 3200 W. VALHALLA DRIVE, BURBANK CA 91505
Xavier Aguilera director, officer: CFO/Treasurer,Exec.V.P.& Secy 3200 W. VALHALLA DRIVE, BURBANK CA 91505
Michele Janes officer: Vice President of Admin. 3200 W. VALHALLA DRIVE, BURBANK CA 91505

Grapefruit USA (Grapefruit USA) Headlines